Aqtual is a startup based in the United Kingdom, most recent round Series B, 1 tracked investor.
Aqtual is a company headquartered in the United Kingdom. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Aqtual develops precision medicine products for chronic disease management and oncology using a novel cell-free DNA platform to create blood tests for disease detection, monitoring, and patient stratification.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.